hat
Atenn patan AstraZeneca a sou tablèt Zomig ekspire sou Novanm 14, 2012, ak ekstansyon eksklizivite pedyatrik li yo ekspire sou 14 me 2013. Patant lan nan sèten peyi Ewopeyen te deja ekspire tou, ak jenerik Maker dwòg Actavis lage yon vèsyon jenerik nan peyi sa yo, kòmanse nan mwa Mas 2012.
eng
AstraZeneca's U.S. patent on Zomig tablets expired on November 14, 2012, and its pediatric exclusivity extension expired on May 14, 2013.The patent in certain European countries has already expired too, and generic drug maker Actavis released a generic version in those countries, starting in March 2012.